Inspite of accomplishing a complete response with exceptional induction therapy, minimal residual disorder usually persists, necessitating consolidation therapy to mitigate the risk of relapse by reducing residual sickness. In sufferers which have gained seven+3 induction therapy, consolidation therapy is initiated with large-dose cytarabine, ofte